Vita-Salute San Raffaele University Milan, Milan, Italy.
IRCCS San Raffaele Scientific Institute, Milan, Italy.
Eye (Lond). 2023 Sep;37(13):2679-2684. doi: 10.1038/s41433-023-02383-5. Epub 2023 Feb 7.
To assess the choroidal vascularity index (CVI) in patients affected by Leber hereditary optic neuropathy (LHON) compared to patients affected by dominant optic atrophy (DOA) and healthy subjects.
In this retrospective study, we considered three cohorts: LHON eyes (48), DOA eyes (48) and healthy subjects' eyes (48). All patients underwent a complete ophthalmologic examination, including best-corrected visual acuity (BCVA) and optical coherence tomography (OCT) acquisition. OCT parameters as subfoveal choroidal thickness (Sub-F ChT), mean choroidal thickness (ChT), total choroidal area (TCA), luminal choroidal area (LCA) were calculated. CVI was obtained as the ratio of LCA and TCA.
Subfoveal ChT in LHON patients did not show statistically significant differences compared to controls, while in DOA a reduction in choroidal thickness was observed (p = 0.344 and p = 0.045, respectively). Mean ChT was reduced in both LHON and DOA subjects, although this difference reached statistical significance only in DOA (p = 0.365 and p = 0.044, respectively). TCA showed no significant differences among the 3 cohorts (p = 0.832). No changes were detected in LCA among the cohorts (p = 0.389), as well as in the stromal choroidal area (SCA, p = 0.279). The CVI showed no differences among groups (p = 0.898): LHON group was characterized by a similar CVI in comparison to controls (p = 0.911) and DOA group (p = 0.818); the DOA group was characterized by a similar CVI in comparison to controls (p = 1.0).
CVI is preserved in DOA and LHON patients, suggesting that even in the chronic phase of the neuropathy the choroidal structure is not irreversibly compromised.
评估 Leber 遗传性视神经病变(LHON)患者、显性视神经萎缩(DOA)患者和健康受试者的脉络膜血管指数(CVI)。
在这项回顾性研究中,我们考虑了三个队列:LHON 眼(48 只)、DOA 眼(48 只)和健康受试者眼(48 只)。所有患者均接受了全面的眼科检查,包括最佳矫正视力(BCVA)和光学相干断层扫描(OCT)采集。OCT 参数包括中心凹下脉络膜厚度(Sub-F ChT)、平均脉络膜厚度(ChT)、总脉络膜面积(TCA)、脉络膜管腔面积(LCA)。CVI 通过 LCA 与 TCA 的比值获得。
与对照组相比,LHON 患者的中心凹下脉络膜厚度(Sub-F ChT)无统计学差异,而 DOA 患者的脉络膜厚度减少(p=0.344 和 p=0.045)。LHON 和 DOA 患者的平均脉络膜厚度均降低,但仅在 DOA 患者中差异具有统计学意义(p=0.365 和 p=0.044)。3 个队列之间的 TCA 无显著差异(p=0.832)。各组之间的 LCA 无变化(p=0.389),基质脉络膜面积(SCA,p=0.279)也无变化。各组之间的 CVI 无差异(p=0.898):LHON 组与对照组(p=0.911)和 DOA 组(p=0.818)相比,CVI 相似;DOA 组与对照组(p=1.0)相比,CVI 相似。
CVI 在 DOA 和 LHON 患者中得到保留,表明即使在神经病的慢性阶段,脉络膜结构也没有不可逆转地受损。